Clinical Research Directory

Inclusion Criteria: * Subjects able to read, understand and sign consent * Subjects 18 years or older with: 1. Moderate to severe OSA (AHI of ≥ 15 to ≤ 50 as determined by a Diagnostic PSG recording within 2 months of inclusion) 2. Subject agrees not to use any type of additional OSA therapy including PAP therapy throughout the course of the study Exclusion Criteria: Subjects who meet any of the following criteria will be excluded from participation in the clinical trial: * \< 18 years of age * AHI \< 15(mild OSA) * AHI \> 50 * Subjects with \> 20% of AHI score accounted for from central apnea * More than 10% of Total Sleep Time (TST) with blood O2 saturation (SaO2) below 70% * Subjects successfully treated with prescribed PAP therapy * Tonsillar hypertrophy ≥3 * Subjects with significant active comorbid respiratory or cardiac disease (such as COPD or Heart Failure) * Subjects requiring regular use of supplemental oxygen * Nasal airway obstruction as seen on examination * Congenital malformations of the upper airway, larynx, pharynx, oral cavity or tongue * Narrowing of hypopharynx airspace more than velopharyngeal airspace as seen on examination (suspected epiglottic obstruction) * History of radiation therapy to the neck or upper respiratory tract * Subjects with bleeding disorders, unresolved impaired immunity for any reason, or heart attack within the last six months * Subjects with an existing tongue stud/piercing * Females who are pregnant (anesthesia risk) * Allergy to LTR materials (Silicone, PEEK, Polyurethane) * Subjects who have in the surgeon's judgment unusual anatomy that would interfere with treatment or increase the risk for the procedure * Unable and/or unwilling to comply with study requirements